| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |